Ravi Coutinho bought a health insurance plan thinking it would give him access to mental health providers. But even after 21 phone calls and multiple hospitalizations, no one could find him a therapist.

The Federal Trade Commission said pharmacy benefit managers created a "perverse drug rebate system" that artificially inflated the cost of insulin.

Insurers’ failures to update their provider directories have led to dire consequences for people seeking mental health care. Here's how you can navigate these challenges to find treatment.

More pregnant women are being diagnosed with dangerously high blood pressure, which risks the life of the parent and child. Montana is one of the states improving screening and treatment.

Infectious diseases experts say many Americans fell behind on their whooping cough vaccinations during the COVID-19 pandemic, which they say has compounded the recent uptick in cases.

Chemicals used in food packaging and linked with health problems have been detected in the human body. The chemicals can move from packaging into food.

The nasal spray option could encourage more people who have fears of doctors or needles to inoculate themselves against the flu.

Three years ago, the cigarette giant acquired Vectura, a British pharmaceutical firm that makes asthma inhalers, raising health groups’ ire. Now, it’s selling the business for almost $200 million.

With genetic samples from the infamous Wuhan market, a new study makes the case that raccoon dogs are likely the animal that infected humans. Proponents of the lab leak theory are dubious.

Progress in preventing infections was being made in the country with Europe's second-highest number of HIV cases. Then came the Russian invasion.

Washing your body seems like a no-brainer. But once you get into the details, things get complicated. Dermatologists offer surprising advice on how often to shower, when to toss your loofah and more.

It’s been almost a year since the Food and Drug Administration approved the first genetic treatments for sickle cell disease. So far, only a few patients have received the long-awaited treatments.

The U.S. Food and Drug Administration currently lists amoxicillin in its database of drugs experiencing a shortage.

After decades of devastating increases driven by fentanyl and other toxic street drugs, overdose deaths are dropping sharply in much of the U.S. The trend could mean roughly 20,000 fewer deaths in 2024.

A new report shows rapid development of new cancer treatment and detection is helping people live more. But more people are also getting diagnosed, and at younger ages.